Bausch + Lomb eye-drop drug misses mid-stage study main goal

Bausch + Lomb eye-drop drug misses mid-stage study main goal

来源:Reuters发布于 2026-11-19

Bausch + Lomb, said on Thursday its experimental ​eye-drop treatment failed to show a significant reduction ‌in pain over the first 24 hours after laser eye surgery in a mid-stage study.

相关标的:BLCO

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。